ly3437943 retatrutide triple agonist glp-1 gip glucagon What Is Retatrutide? The Peptide Explained Retatrutide, a triple agonist, delivered
Description
Be sure to let your clinician know about all medications youre taking
(2014) 221:T3141
For example, the LEADER trial showed that Liraglutide significantly reduced the risk of major adverse cardiovascular events (MACE) by 13% and cardiovascular death by 22% in comparison to placebo
GIP primarily stimulates insulin secretion, affects glucagon in glucose-dependent ways, and influences fat metabolism
In 2023, Eli Lilly entered the market with Zepbound (tirzepatide), boasting over 20% weight loss at 72 weeks and a slightly lower price
